Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
African swine fever virus hemagglutinin protein, commonly referred to as CD2v, is a critical type I transmembrane glycoprotein encoded by the EP402R gene of the African swine fever virus (ASFV) [1, 10]. It is the only viral protein identified on the external envelope of the virion and shares significant structural homology with the host T-lymphocyte adhesion receptor CD2 [1, 4, 8]. CD2v is primarily responsible for the characteristic hemadsorption (HAD) phenomenon, in which porcine erythrocytes bind to the surface of infected macrophages and extracellular virus particles [1, 2, 5]. This interaction is thought to facilitate viral dissemination throughout the host and contribute to immune evasion by shielding the virus from neutralizing antibodies [1, 4, 5]. Additionally, CD2v functions as a potent virulence factor by modulating host cell signaling, including the activation of the NF-κB and JAK2-STAT3 pathways, which can lead to the induction of apoptosis in bystander lymphocytes and macrophages [6, 10, 12]. Due to its central role in pathogenesis and its high immunogenicity, CD2v is a major target for the development of subunit and live-attenuated vaccines, as well as a key diagnostic marker for identifying virulent ASFV strains [1, 3, 9, 14].
Induction of protective immune responses through neutralizing antibodies and T-cell activation; blocking of viral hemadsorption and immune evasion mechanisms.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on African swine fever virus hemagglutinin protein (CD2v).